Natco Pharma - Enough Correction

523
CMP 875 on 22.05.25
The stock price dropped 50% between September 2024 and March 2025. In recent days, it has been consolidating near the 800 levels, which is acting as a support zone, as shown on the chart.
MACD shows a likely crossover, too.
If it gives an upside move, further targets may be 1080/1180 or more.
One has to keep the position size according to the risk management.
The setup will go weak if it sustains below 800-775 levels.
All these illustrations are only for learning and sharing purposes, not a piece of trading advice in any way.
All the best.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.